MedTrace Logo

Antigravity Treadmill With Alter G on the Postural Stability of Traumatic Lower Limb Injuries

NCT05285020 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-03-17

No results posted yet for this study

Summary

This prospective randomised study aimed to test the investigators's hypothesis that anti-gravity treadmill therapy has beneficial effects on postural stability tests over a standard rehabilitation protocol in patients who have suffered traumatic injuries of the lower limb, demonstrating an improvement in the Biodex platform's values.

The total of 30 patients participated in this study (n=30). There were 15 subjects in control group and 15 in experimental group.

Conditions

  • Injury Traumatic
  • Muscle Injury
  • Bone Injuries Joints
  • Tendon Injuries
  • Lower Limb Injury
  • Ligament Injury

Interventions

OTHER

Alter G

It is anti-gravity treadmill treatment on Alter G. They will start with a 30-50% body weight load during the first week that will be progressively increased to 50-70% during the second (5% more each day during the 10 sessions as far as possible). The slope will be 0% and the speed 2-3km/h the first week and 3-4 km/h the second. Treatment will be performed during 15 minutes for two weeks (10 sessions).

OTHER

Parallel bars and Scale

It is a re-education of the gait at the parallel bars with a progressive load in scale controlled by the patient during 10 minutes for two weeks.

OTHER

Standard rehabilitation protocol

It is the hospital's standard protocol for that injuries once a day for two weeks.

Sponsors & Collaborators

  • FREMAP Mutual Insurance Company for Occupational Accidents and Diseases

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2022-07-10
Completion
2022-07-24

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05285020 on ClinicalTrials.gov